0001437749-24-006507.txt : 20240304 0001437749-24-006507.hdr.sgml : 20240304 20240304210337 ACCESSION NUMBER: 0001437749-24-006507 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240229 FILED AS OF DATE: 20240304 DATE AS OF CHANGE: 20240304 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Roberts David B CENTRAL INDEX KEY: 0001365731 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33092 FILM NUMBER: 24717947 MAIL ADDRESS: STREET 1: 55 BRADFORD STREET CITY: NEEDHAM STATE: MA ZIP: 02492 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEMAITRE VASCULAR INC CENTRAL INDEX KEY: 0001158895 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-221-2266 MAIL ADDRESS: STREET 1: 63 SECOND AVENUE CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 rdgdoc.xml FORM 4 X0508 4 2024-02-29 0001158895 LEMAITRE VASCULAR INC LMAT 0001365731 Roberts David B C/O LEMAITRE VASCULAR, INC. 63 SECOND AVENUE BURLINGTON MA 01803 1 1 President and Director 0 Common Stock 2024-02-29 4 A 0 2649 0 A 19329 D Common Stock 2024-02-29 4 M 0 6 0 A 19335 D Common Stock 2024-02-29 4 F 0 196 70 D 19139 D Dividend Equivalent Rights 2024-02-29 4 M 0 6.683 0 D Common Stock 6.683 20.0592 D These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years. Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals. Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. /s/ David C. Hissong 2024-03-04